IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

South African firm Aspen acquires Merck & Co. API plants and 11 finished-dosage products for $1 billion

12:03 PM MDT | June 28, 2013 | Deepti Ramesh

Aspen (Durban, South Africa), the ninth-largest generic pharmaceutical company in the world, says it has signed an agreement with Merck & Co. (Whitehouse Station, NJ), which is called MSD outside the United States and Canada, for the acquisition of an active pharmaceutical ingredient (API) manufacturing business, which is located in the Netherlands with a satellite facility and sales office in the United States. The API business manufactures for MSD and the market generally. Aspen has also reached an agreement on an option to acquire a portfolio of 11...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa